(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

INNOVAFORM

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

INNOVAFORM

ST13

US500000079409988

Class

40, 42

Filing

79409988

Registration

7862700

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

25

Latest update

04/03/2026

Trademark type

Word

Nice classes

40, 42

Filing date

08/20/2024

Registration date

07/15/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/15/2025

Last transaction

04/03/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

32

Owner location

BE

Examiner

REID, CAILE MAUREEN

Law office

N50

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

Capsugel Belgium NV

Representatives

Lawrence J. Crain Greer, Burns & Crain, Ltd.

Technical classification

Nice Classes

Class 40Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 40

Custom manufacturing services of pharmaceuticalsin particularcustom manufacturing of pharmaceuticals using a proprietary technology platform for capsule and any other oral solid dosage formscustom manufacture of pharmaceutical encapsulation technologies

Class 42

Scientific and technological consulting services in the field of pharmaceutical developmentspecifically for the formulationcustomization and encapsulation of capsules and other oral solid dosage forms; scientific and technological consulting services for creating being new product design of pharmaceutical capsule and any other oral solid dosage form delivery solutions; scientific and technological consulting services in relation to new product design capsule and any other oral solid dosage form expertise; product development services using a proprietary technology platform for developing capsule and any other oral solid dosage formsproduct development of encapsulation technologies

Publications

History of USPTO decisions and trademark events.

25 publications found

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

02/26/2026

FICS

FINAL DISPOSITION NOTICE SENT TO IB

02/11/2026

FIMP

FINAL DISPOSITION PROCESSED

02/11/2026

CORN

CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED

10/15/2025

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

10/15/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

07/15/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

07/15/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

05/27/2025

PUBO

PUBLISHED FOR OPPOSITION

05/27/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/21/2025

RFNT

REFUSAL PROCESSED BY IB

05/04/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/28/2025

ATRV

ATTORNEY REVIEW COMPLETED

04/28/2025

CRCV

CORRECTION TRANSACTION RECEIVED FROM IB

04/25/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/17/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/17/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/17/2025

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

04/11/2025

RFRR

REFUSAL PROCESSED BY MPU

04/11/2025

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

03/06/2025

CNRT

NON-FINAL ACTION WRITTEN

03/06/2025

DOCK

ASSIGNED TO EXAMINER

02/25/2025

MAFR

APPLICATION FILING RECEIPT MAILED

11/22/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/22/2024

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

11/21/2024

Continuous trademark protection

Get notified about every new filing that threatens INNOVAFORM or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.